
The companies focus on fibrosis and oncology, and novel treatments for respiratory conditions, respectively

The new site will expand research capabilities across immunology, neuroscience and oncology

The use of Rinvoq in non-segmental vitiligo is under regulatory review by the US FDA

This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments

As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?

Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.

Rinvoq is the first and only systemic medication approved in the EU for NSV

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year's congress revealed for pharmaceutical organisations. Together, they...

The acquisition includes clinical-stage candidates for atopic dermatitis and asthma

Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.

The companies plan to research and develop 12 new cancer treatments

Spanning four dimensions of skin health, the framework introduces 15 terms and definitions